Compliance updated on Sep 10, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Polyrizon Ltd

PLRZ ✓ COMPLIANTFree checks used up today ☆ Track — members

NASDAQ · Healthcare · Biotechnology & Medical Research ·

USA Micro Cap Analyst: N/A

Last Close

$8.53

▼ -2.51%

Market Cap $20.69M · Vol 551

Price charts are for members

Interactive price history from intraday to 5 years, on every stock and ETF.

See plans

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$20.69M

Micro Cap

Div Yield

N/A

EPS Growth

N/A

YoY

RSI (14)

42.19

Momentum

Beta

N/A

vs Market

52W High

$18.18

51.87% below

52W Low

$2.88

203.82% above

Volume

551

Avg 5.91K

P/B

0.65

Price-to-book

ROE

N/A

Return on equity

Free Float

98.53%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Polyrizon Ltd (PLRZ) stock is Shariah compliant

You’ve used your 10 free compliance checks today

Choose a plan

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share.Members see the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does PLRZ pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-14.79%

-19.98%

-40.72%

-41.73%

YTD

+0.47%

+30.43%

N/A

Financials & Valuation

TTM · Annual

Total Revenue	$0.00
Net Income	$-3,335,000.00
Revenue Growth (YoY)	N/A
Gross Margin	N/A
Operating Margin	N/A
Net Profit Margin	N/A
ROE	N/A
ROA · ROIC	-24.72% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	N/A
P/B	0.65
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	2.37M

Technical Indicators

50-Day SMA	$10.70
200-Day SMA	$12.74
RSI (14)	42.19
Beta	N/A
52-Week High	$18.18
52-Week Low	$2.88

Volume Today	551
Avg Daily Volume (30D)	5.91K
Relative Volume	0.09x
Volatility (10D)	99.06
Volatility (30D)	74.90
Free Float	98.53%

Analyst Consensus

N/A

Current Price $8.53

Mean Target N/A

52W Low$2.88 52W High$18.18

Current

Target

$2.88 $18.18

Current Analyst target

· 0 analysts

Identifiers

ExchangeNASDAQ

FIGIBBG0194GNBX3

ISINIL0011814113

CountryIsrael

Sub-IndustryBio Therapeutic Drugs

Earnings DateN/A

TypeStocks

Instrument TypeADR American Depositary Receipt

Similar Halal Stocks

2359.HK WuXi AppTec Co., Ltd. -6.02% ARGX.BR argenx SE -0.41% ARGX argenx SE -1.61% GMAB.CO Genmab A/S +1.30% GMAB Genmab A/S +1.09%

Company Profile

Polyrizon Ltd is an Israel-based biotechnology company. The Company is primarily engaged and specializing in the development of medical device hydrogels delivered in the form of nasal sprays, which form a thin hydrogel-based shield containment barrier in the nasal cavity that can provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. Its naturally occurring building blocks, is delivered in the form of nasal sprays, and potentially functions as a biological mask with a thin shield containment barrier in the nasal cavity. The Company is focused not only on the development of intranasal products, but also on commercialization. The Company cooperates with medical specialists and researchers..